Depression and neuroplasticity: implication of serotoninergic systems

• Published in: Therapie Vol. 60; no. 5; p. 461
• Main Authors: Daszuta, Annie, Ban, Sr, Mounira, Soumier, Amélie, Hery, Micheline, Mocaer, Elisabeth
• Format: Journal Article
• Language: French
• Published: France 01.09.2005
• Subjects: Brain - physiology; Brain - physiopathology; Depression - physiopathology; Humans; Neuronal Plasticity; Serotonin - physiology
• ISSN: 0040-5957
• DOI: 10.2515/therapie:2005066

Neuroplasticity contributes to both normal and pathological brain function. A recent hypothesis links depression to lack of adaptive responses to stress or other aversive stimuli, and effects of antidepressant treatments on adult neurogenesis are more and more extensively studied because of the structural changes involved in the pathophysiology of depression. Indeed, neuronal remodelling in hippocampal formation is associated with chronic stress and is reversed by antidepressant treatments in animals. Decrease in hippocampal volume has also been associated to cognitive deficits in patients with major depression. Interestingly, serotonergic (5-HT) systems play a major role both as antidepressants and by increasing hippocampal neurogenesis through various receptor subtypes. Recently, we have also demonstrated that agomelatine, a new antidepressant drug having serotonergic and melatonergic properties, can increase proliferation and survival of newly formed hippocampal cells. Although the mechanisms underlying such effects are still unknown, these data reinforce the view that changes in hippocampal neurogenesis might belong to the cellular correlates of mood disorders.